Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Descovy, Truvada And The Politics Of PrEP

Aug 14 2019

• By Michael McCaughan

Pre-exposure-PrEP-pill

Related Content

<em>Truvada</em> PrEP REMS Needs More Work, FDA Panel Says

May 14 2012

Gilead, US FDA Ponder Innovative Designs For Descovy HIV Prevention Study In Women

Aug 12 2019

Drug Pricing Hearing Takes A Partisan Turn As Gilead’s O’Day Holds His Own

May 17 2019

Gilead's Descovy HIV Prevention Indication Should Exclude Women, US FDA Advisory Cmte. Says

Aug 08 2019

Gilead’s Marketing Of Descovy For HIV Prevention Should Not Suggest Superiority To Truvada

Aug 09 2019

Related Companies

Gilead Sciences, Inc.

Additional Topics

United States Advisory Committees Pricing Debate Drug Review Drug Approval Standards Politics Regulation Infectious Diseases BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window